{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:52:16Z","timestamp":1756075936939,"version":"3.33.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,1,15]]},"DOI":"10.2169\/internalmedicine.3755-24","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T22:12:54Z","timestamp":1717020774000},"page":"287-291","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous Thrombolysis for Pediatric Ischemic Stroke Secondary to Cancer Therapy-related Cardiac Dysfunction"],"prefix":"10.2169","volume":"64","author":[{"given":"Futoshi","family":"Eto","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Nezu","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Sakahara","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Karakawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sawicki KT, Sala V, Prever L, et al. Preventing and treating anthracycline cardiotoxicity: new insights. Annu Rev Pharmacol Toxicol 61: 309-332, 2021.","DOI":"10.1146\/annurev-pharmtox-030620-104842"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Leow AST, Sia CH, Tan BYQ, et al. Characterisation of acute ischemic stroke in patients with left ventricular thrombi after myocardial infarction. J Thromb Thrombolysis 48: 158-166, 2019.","DOI":"10.1007\/s11239-019-01829-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bigi S, Dulcey A, Gralla J, et al. Feasibility, safety, and outcome of recanalization treatment in childhood stroke. Ann Neurol 83: 1125-1132, 2018.","DOI":"10.1002\/ana.25242"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Harrar DB, Benedetti GM, Jayakar A, et al. Pediatric acute stroke protocols in the United States and Canada. J Pediatr 242: 220-227.e7, 2022.","DOI":"10.1016\/j.jpeds.2021.10.048"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Das B. Pharmacotherapy for cancer treatment-related cardiac dysfunction and heart failure in childhood cancer survivors. Paediatr Drugs 25: 695-707, 2023.","DOI":"10.1007\/s40272-023-00585-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55: 213-220, 2010.","DOI":"10.1016\/j.jacc.2009.03.095"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lip GY. Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy. Postgrad Med J 72: 731-738, 1996.","DOI":"10.1136\/pgmj.72.854.731"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bosman M, Kr\u00fcger D, Van Assche C, et al. Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers. Cardiovasc Res 119: 2579-2590, 2023.","DOI":"10.1093\/cvr\/cvad136"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Levine GN, McEvoy JW, Fang JC, et al. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation 146: e205-e223, 2022.","DOI":"10.1161\/CIR.0000000000001092"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hu YC, Chugh C, Jeevan D, et al. Modern endovascular treatments of occlusive pediatric acute ischemic strokes: case series and review of the literature. Childs Nerv Syst 30: 937-943, 2014.","DOI":"10.1007\/s00381-013-2313-3"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Rivkin MJ, deVeber G, Ichord RN, et al. Thrombolysis in pediatric stroke study. Stroke 46: 880-885, 2015.","DOI":"10.1161\/STROKEAHA.114.008210"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Miyamoto S, Ogasawara K, Kuroda S, et al. Japan Stroke Society guideline 2021 for the treatment of stroke. Int J Stroke 17: 1039-1049, 2022.","DOI":"10.1177\/17474930221090347"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Amlie-Lefond C, Shaw DWW, Cooper A, et al. Risk of intracranial hemorrhage following intravenous tPA (tissue-type plasminogen activator) for acute ischemic stroke is low in children. Stroke 51: 542-548, 2020.","DOI":"10.1161\/STROKEAHA.119.027225"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Dicpinigaitis AJ, Shapiro SD, Nuoman R, et al. Intravenous thrombolysis for treatment of pediatric acute ischemic stroke: analysis of 20 years of population-level data in the United States. Int J Stroke 18: 555-561, 2023.","DOI":"10.1177\/17474930221130911"},{"key":"15","unstructured":"15. Kossorotoff M, Kerleroux B, Boulouis G, et al. Recanalization treatments for pediatric ischemic stroke in France. JAMA Netw Open 5: e2231343, 2022."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kara G, Ta\u015fo\u011flu \u00d6, Dizdar \u00d6, et al. Stroke due to doxorubicin-induced cardiac toxicity. Med Oncol 26: 506-507, 2009.","DOI":"10.1007\/s12032-008-9134-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lee EJ, Yoon BW. Acute ischemic stroke in a young patient with left ventricular thrombus attributed to doxorubicin cardiomyopathy. Case Rep Neurol 12: 178-182, 2020.","DOI":"10.1159\/000502414"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hwang J, Eun MY. A case of acute ischemic stroke caused by doxorubicin-induced cardiomyopathy in a patient with synovial sarcoma. Acta Neurol Belg 123: 1659-1661, 2023.","DOI":"10.1007\/s13760-023-02243-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kobayashi M, Tanaka R, Yamashiro K, et al. Pre-existing mobile cardiac thrombus and the risk of early recurrent embolism after intravenous thrombolysis: a case report. J Stroke Cerebrovasc Dis 24: e161-e163, 2015.","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.001"},{"key":"20","unstructured":"20. Clottes P, Bochaton T, Mechtouff L, et al. Safety and efficacy of reperfusion therapies in acute ischemic stroke related to left ventricular thrombus: a retrospective cohort study. Rev Neurol (Paris). Forthcoming."},{"key":"21","unstructured":"21. Thavendiranathan P, Negishi T, Somerset E, et al. Strain-guided management of potentially cardiotoxic cancer therapy. J Am Coll Cardiol 77: 392-401, 2021."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/2\/64_3755-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T03:30:18Z","timestamp":1737171018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/2\/64_3755-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3755-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"3755-24"}}